D

Dyne Therapeutics

DYN

42.140
USD
-0.77
(-1.79%)
مغلق
حجم التداول
47,880
الربح لكل سهم
0
العائد الربحي
0
P/E
-8
حجم السوق
2,880,498,895
أصول ذات صلة
A
ACEL
-0.670
(-5.49%)
11.540 USD
G
GGR
-0.10000
(-6.67%)
1.40000 USD
الأخبار المقالات

العنوان: Dyne Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Dyne Therapeutics Inc is a biotechnology company focused on providing therapeutics for patients with genetically driven diseases. The company overcomes the limitations of muscle tissue delivery and modern oligonucleotide therapeutics for muscle diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy. The company's product candidates are DYNE-101 and DYNE-251, both arein the ongoing phase 1/2 clinical trial.